Left ventricular aneurysms (LVAs) are found in 10 to 30% of patients suffering from anterior myocardial infarction1. Traditionally, scar reduction has required the use of invasive surgical techniques2. The Surgical Treatment for Ischemic Heart Failure (STICH) trial is a classic trial comparing coronary artery bypass grafting (CABG) alone with a combined procedure of CABG and surgical ventricular reconstruction3. Currently, catheter-based procedures for direct modification of the left ventricle are represented by the Parachute device (CardioKinetix Inc., Menlo Park, CA, USA) and the Revivent TC™ device (BioVentrix Inc., San Ramon, CA, USA)4,5. We report our single-centre experience and outcomes ...
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com